130 likes | 141 Vues
Dermal Fillers and Botulinum Toxin Market
E N D
Contrive Datum InsightsGlobal Research And Consulting A complete solution to explore all the potential aspect to drive the growth of the business industries. Dermal Fillers and Botulinum Toxin Market
About Us Contrive Datum Insights (CDI) is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. CDI’s experienced team of Analysts, Researchers, and Consultants uses proprietary data sources and various tools and techniques to gather, and analyse information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Each CDI syndicated research report covers a different sector — such as chemicals, materials, metals & mining, pharmaceuticals, energy, automotive, food and beverages, semiconductors, med-devices, consumer goods and information technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports strive to serve the overall research requirement of clients.
Services Offered : • Market Intelligence & Market Opportunity Assessment • Market Size & Segmentation • Market Entry Strategy • Competitor Benchmarking • Pricing Intelligence • Customer Intelligence • Sourcing Intelligence • New-Generation Products & Technologies • Distribution & Sales Channel Assessment
Clientele: Some of the global leading clients that we have served:
Clientele: Some of the global leading clients that we have served:
MarketOverview The global dermal fillers and botulinum toxin market is expected to grow at a CAGR of 6.1% during the forecast period (2018-2030). • This growth can be attributed to the growing demand for minimally invasive procedures and the prevalence of skin aging. Additionally, the growing demand for botulinum toxin in the Asia-Pacific region is another key factor fueling the growth of this market. • Dermal fillers and botulinum toxin are the two main treatments used for cosmetic purposes. Dermal fillers are used to improve facial lines and wrinkles, while botulinum toxin is most commonly used to reduce crow's feet and frown lines.
Regional Insights The US accounted for approximately 49.5% share of the global market in 2021 and is expected to witness continued profitability growth over the next decade. Over the years, medical cosmetic technology in the United States has improved tremendously and gained traction. For patients in need of medical assistance, the country's advanced technology has provided a range of products and solutions. Botulinum toxin has been widely used in cosmetic medicine in the United States. During the forecast period, the US market is expected to develop rapidly owing to increasing demand for minimally invasive cosmetic surgery. According to FMI, Japan had a market share of about 6.0% in 2021. Increased public awareness and a growing younger population will lead to greater adoption of dermal fillers and botulinum toxin treatments. This factor is expected to fuel the expansion of the dermal fillers and botulinum toxin market in Japan.
The Dermal Fillers and Botulinum Toxin Market has been segmented into: • ByType • Hyaluronic Acid Based Dermal Fillers • Non-hyaluronic Acid Based Dermal Fillers • Botulinum Toxin • Other • ByApplication • Aesthetic Volume Restoration • Wrinkle Reduction • Other
Strategic Developments • On June 11, 2021, Galderma announced the launch of Alluzience, a ready-to-use neuromodulator or wrinkle reduction injectable in Europe. Alluzience is a precisely designed liquid version of botulinum toxin type A. • On August 31, 2021, Merz Pharma launched XEOMIN (incobotulinum toxin A) for the symptomatic treatment of chronic exudates due to nervous system or other diseases in children and adolescents aged 2 to 17 years who weigh less than 12 kg. • On September 11, 2019, Merz invested EUR 15 million to expand its manufactured product range and strengthen its presence in Biopharma Park by building a new plant for Belotero dermal fillers in Dessau.
Market Players • Allergan plc., • Galderma SA, • Merz Pharma GmbH & Co. KGaA, • Sanofi, Anika Therapeutics, • Inc., LG Life Sciences, • SunevaMedical,Inc., • Hyaltech, • Speciality European Pharma, • HUGEL, Inc., • Grex Pharma SaS, • Daewoong Pharmaceuticals, • Medy-Tox Inc., • TEOXANE Laboratories, • SciVision Biotech Inc., • And Others.
Customer Experiences “Very happy with the service. Report quality as well as response time for my custom market study was great. I am looking forward to work with Contrive Datum Insights (CDI) in future. “ “We are satisfied with research report offered by Contrive Datum Insights (CDI) .” We appreciate your support throughout the project.” "You and your team did a terrific job on this project.” CDI will be at the top of our list in the future for market research projects.” G. Luca, A+ Outsourced Marketing Consulting Company (privacy requested) Europe based Fortune 500 Company (privacy requested)
By associating with Contrive Datum Insights (CDI) , customer can enjoy following benefits: • One-Stop-Destination for all research needs (Syndicate and Custom Reports) • Reduced Budget and Faster Turnaround Time • Focused Research Team - Contrive Datum Insights (CDI) can arrange a dedicated team of 2-3 resources with 1 Research Manager , who will look after any ad-hoc needs of the client • Dedicated Account Manager • 24/7 availability for any custom needs of the client • Flexible Partnering Model to accommodate client’s research needs • Access to Data-Cuts related to required Market for global region • ▪ Industry Update on Weekly/Bi-Weekly/Monthly basis • ▪ Market Trend Analysis on Monthly/Quarterly basis Benefits of Association
Thank You! To know more about us, please visit our website: www.contrivedatuminsights.com For sales queries or new topics email us on: anna@contrivedatuminsights.com